Pomalidomide, bortezomib and dexamethasone after one prior line of therapy in bortezomib-pretreated multiple myeloma: a subanalysis of the OPTIMISMM phase 3 trialJ. Lindsay,M. Dimopoulos,K. Weisel,P. Moreau,Jr. Anderson L. D.,D. White,J. San Miguel,P. Sonneveld,M. Engelhardt,M. Jenner,A. Corso, J. Duerig,M. Pavic,M. Salomo,E. Casal,R. Jiang,S. Srinivasan, T. Biyukov, L. Grote,T. Peluso, P. RichardsonBRITISH JOURNAL OF HAEMATOLOGY（2020）引用 0|浏览31暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
